Public health at scale: Lessons from implementing AI across government health programmes

Adoption depends on how new tools fit within existing infrastructure.

Public health systems are asked to deliver care for entire populations, often with far fewer specialists and diagnostic resources than those populations require. The result is a persistent gap between the demand for care and the capacity to deliver it. Delays in diagnosis remain common, particularly in government health systems that serve large rural or underserved communities.

India’s radiology workforce illustrates the scale of this challenge. Roughly 15,000 radiologists serve a population of more than 1.4 billion people, and most are concentrated in major urban hospitals. District facilities and primary care centres frequently operate without on-site specialists. Whilst imaging may be available, timely interpretation often is not.

When this happens, the entire healthcare pathway slows down. Patients wait longer for answers, and clinicians must make decisions without specialist input. Screening programs struggle to operate at the scale required to detect disease early. New diagnostic technologies are beginning to change that equation.

AI as a force multiplier for diagnostics
Artificial intelligence (AI)-based imaging tools are increasingly being deployed within government health programmes to strengthen diagnostic capacity. When integrated directly into clinical workflows, these systems can analyse medical images quickly, identify suspected abnormalities, and help clinicians prioritise urgent cases. The objective is not to replace clinical expertise, but to extend it across health systems where specialists remain scarce.

The importance of such systems becomes clear in time-critical conditions. Stroke care, for instance, often operates through hub-and-spoke networks in public hospital systems. District hospitals provide initial evaluation, whilst specialised centres deliver advanced interventions.

In these settings, early recognition and rapid referral are essential. Imaging tools capable of analysing scans immediately can help clinicians identify stroke earlier and accelerate the referral process, improving the chances that patients receive treatment within the narrow therapeutic window available.

AI and population-level disease screening
Large-scale disease screening programs highlight a similar opportunity.

Tuberculosis continues to place a heavy burden on global health systems. The World Health Organization (WHO) Global Tuberculosis (TB) Report 2025 estimates that 10.7 million people developed TB in 2024, underscoring the urgent need for screening approaches that can operate at a population scale. In response, the WHO now recommends computer-aided detection (CAD) software to assist in interpreting digital chest X-rays during TB screening programs, enabling healthcare providers to rapidly identify suspected cases and prioritise confirmatory testing.

For countries running community-level screening programs, the challenge is not only detection but scale. Large screening drives can produce thousands of chest X-rays in a matter of days, far more than available radiology teams can realistically review. Systems that automatically highlight suspicious scans allow health workers to move quickly, directing attention to patients who may require confirmatory testing or urgent care.

Similar approaches are now being explored for other high-burden conditions, including lung diseases and breast cancer. In district hospitals and rural clinics where specialist access is limited, these systems provide clinicians with an additional layer of diagnostic support that can strengthen referral pathways across the health network.

Technology only works when it fits the system
Experience from implementing such technologies across government programs has also revealed an important operational lesson: Adoption depends heavily on how well new tools fit within existing health-system infrastructure.

Public health facilities already operate under significant workload pressures. New technology rarely survives long in busy public hospitals if it adds extra steps to an already stretched workflow. Tools that sit inside existing radiology platforms, hospital information systems, or telemedicine networks are far more likely to be used consistently, simply because clinicians encounter them within the normal flow of patient care.

Equally important is the role of frontline health workers. In many government programmes, nurses, technicians, and primary care physicians are the first point of contact for patients. Diagnostic systems that provide clear visual indicators or triage signals can help these providers recognise potential abnormalities and prioritise patients who need further investigation.

Governance, trust, and responsible deployment
Expanding these systems across national health programs also brings new responsibilities. Public health networks generate vast clinical datasets through routine care and screening activities. These data can strengthen diagnostic tools over time, but only when clear safeguards exist for clinical validation, privacy protection, and ethical oversight.

Building those safeguards requires close collaboration between clinicians, researchers, public health authorities, and technology developers so that new diagnostic tools remain transparent, accountable, and clinically reliable as they scale.

It's also crucial to recognise what these technologies are meant to do. They are not substitutes for clinical judgment. Rather, they extend the reach of limited specialist expertise across health systems that must serve millions of patients. Tasks such as initial image review or prioritising suspicious cases can be handled quickly by automated systems, allowing clinicians to devote more time to treatment decisions, patient management, and the complex cases that demand expert attention.

The future of public health at scale
Public health has always depended on scale. As governments continue investing in digital health infrastructure, technologies that extend diagnostic capacity across large populations are likely to become an increasingly important component of national health systems.

The tools now exist. The next challenge is ensuring they are deployed widely and responsibly so that every health facility, whether in a major city or a remote district, can benefit from the diagnostic expertise needed to deliver timely and effective care.